Notificação de entrada na fase nacional - PCT
#1.3
10/29/2024
RPI 2808
Application data
Number
112024013667Type
Filing
Publication
PCT
US2023060080 The application was filed at the INPI on 01/04/2023. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 10/29/2024. We update with every new RPI gazette, published weekly.
Applicants
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
IE
Inventors
B. K. (pessoa física)
US
M. D. (pessoa física)
US
P. S. (pessoa física)
US
P. F. (pessoa física)
US
IPC Classification
Priority claims
US
63/296.359 · 01/04/2022
US
63/341.986 · 05/13/2022
US
63/342.535 · 05/16/2022
Abstract
USO DE ÓXIDO NÍTRICO INALADO (iNO) PARA TRATAR PACIENTES COM HIPERTENSÃO PULMONAR ASSOCIADA À SARCOIDOSE (PH-SARC). São descritos métodos para tratamento de pacientes com hipertensão pulmonar associada à sarcoidose (PH-SARC) usando óxido nítrico inalado (iNO).
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
10/29/2024
RPI 2808
#1.1
07/16/2024
RPI 2793
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.